Gilead Sciences (GILD) Current Deferred Tax Assets (2009 - 2016)

Gilead Sciences (GILD) has reported Current Deferred Tax Assets for 8 consecutive years, with $857.0 million the latest figure, recorded in Q4 2016.

• Current Deferred Tax Assets for Q4 2016 came in at $857.0 million, up 3.5% year-over-year; the trailing twelve-month figure through Dec 2016 was $857.0 million (up 3.5% YoY), and the FY2016 annual result was $857.0 million, up 3.5% from the prior year.
• Current Deferred Tax Assets was $857.0 million for Q4 2016 at Gilead Sciences, up from $762.0 million in the prior quarter.
• Over five years, Current Deferred Tax Assets peaked at $894.0 million in Q3 2015 and troughed at $193.9 million in Q1 2012.
• Average Current Deferred Tax Assets over 5 years is $501.1 million, with a median of $385.6 million recorded in 2014.
• Year-over-year, Current Deferred Tax Assets plunged 30.2% in 2012 and soared 132.46% in 2015.
• Over 5 years, Current Deferred Tax Assets stood at $262.6 million in 2012, then grew by 26.03% to $331.0 million in 2013, then jumped by 53.47% to $508.0 million in 2014, then soared by 62.99% to $828.0 million in 2015, then gained by 3.5% to $857.0 million in 2016.
• Per Business Quant data, the three most recent Current Deferred Tax Assets figures were $857.0 million in Q4 2016, $762.0 million in Q3 2016, and $835.0 million in Q2 2016.